CBSA: Four Colorado life science companies pitching today to investors at Phoenix conference

By: InnovatioNews Thursday September 18, 2014 0 comments Tags: April Giles, Denver, EndoShape, Fluonic, ValveXchange, ViroCyt


DENVER - Four Colorado companies are presenting today at the inaugural White Hat Life Science Investor Conference in Phoenix, according to the Colorado BioScience Association (CBSA).

The companies are EndoShape, Fluonic and ViroCyt, all based in Boulder. Also presenting is ValveXchange based in Greenwood Village.

"We're excited to be a partner in the 2014 White Hat Life Science Investor Conference and to help showcase four of Colorado's promising bioscience companies during the event," said April Giles, CBSA president and CEO.

The conference is spearheaded by the Arizona BioIndustry Association and presented by the National Venture Capital Association and leading life science associations in the Rocky Mountain Southwest Region, including CBSA.

The conference is showcasing 34 of the region's top life science companies to potential investors.

EndoShape is working to commercialize its Medusa Vascular Plug, which has been cleared by the FDA for sale in the U.S.

Fluonic is working to make infusion drug delivery safer, and ViroCyt is focused on the rapid quantification of viruses.

ValveXchange is developing an improved heart valve replacement.

About the Author: InnovatioNews

InnovatioNews is an online news magazine spotlighting innovative companies, products and people in Colorado. Launched in June of 2012, the site is the recipient of multiple awards.